Lipoprotein(a) [Lp(a)] formation drugs for Atherosclerotic Cardiovascular Disease

2 tracked Lipoprotein(a) [Lp(a)] formation drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the Lipoprotein(a) [Lp(a)] formation page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.

1 Phase 21 Phase 1

Head-to-head evidence: AZD4954 vs HRS-5346

The roster

← all Lipoprotein(a) [Lp(a)] formation drugs